Are Prognostic Indices for Brain Metastases of Melanoma Still Valid in the Stereotactic Era?

Radiation Oncology - United Kingdom
doi 10.1186/s13014-017-0951-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Melanoma Brain Metastases: An Unmet Challenge in the Era of Active Therapy

Current Oncology Reports
Oncology
2013English

Preoperative Stereotactic Radiosurgery for Brain Metastases

Frontiers in Neurology
Neurology
2018English

Stereotactic Radiosurgery for Intraventricular Brain Metastases

Journal of Neurosurgery
SurgeryNeurology
2014English

Metastatic Melanoma: Prognostic Factors and Survival in Patients With Brain Metastases

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2017English

Stereotactic Radiosurgery in the Management of Brain Metastases

JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA
2018English

Stereotactic Radiosurgery With or Without Whole Brain Radiotherapy for Patients With One to Three Melanoma Brain Metastases

Journal of Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2012English

Why Hypofractionate Stereotactic Radiosurgery for Brain Metastases?

CNS oncology
Medicine
2016English

Validation of Recursive Partitioning Analysis, Graded Prognostic Assessment and Basic Score for Brain Metastases as Prognostic Indices Among Patients With Brain Metastases Treated With Radiotherapy in Indonesia

Journal of Radiotherapy in Practice
OncologyRadiologyNuclear MedicineImaging
2019English

Stereotactic Radiosurgery for Metastases in Eloquent Central Brain Locations

Canadian Journal of Neurological Sciences
MedicineNeurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy